Research Outcomes

Sashas EQ is a unique natural pharmaceutical with extensive independent peer reviewed scientific research proving its efficacy.

This research funded a PhD and a Masters Projects with the theses having been successfully defended. The following research papers have been submitted for peer review and have been either published or accepted for publication in journals including Molecular Nutrition and Food and the American Journal of Veterinary Research:

The following are research papers presented at two of the most prestigious equine veterinary scientific meetings held in 2008. It is a very competitive process to have papers accepted for these conferences and Interpath is proud for the researchers who received this recognition for their work. Proceedings published in association with these conferences are distributed to veterinarians around the world.

In-vitro and in-vivo findings have clearly demonstrated the products ability to increase cartilage cell viability, suppress the loss of GAGs from the cartilage matrix, significantly inhibit over-production of PGE2 and Nitric Oxide and provides the full range of GAGs essential for the synthesis of new and healthy cartilage, joints and joint fluid as well as providing chondrocyte and cell proliferation properties.